Related content

ProstaCaid™ inhibits tumor growth in a xenograft model of human prostate cancer

By            

International Journal of Oncology, Vol. 40, Iss. 5, 2012-01 ,pp. : 1339-1344

Spandidos Publications

Access to resources Recommend Favorite

Endogenous accumulation of IFN- in IFN- -R -/- mice increases resistance to B16F10-Nex2 murine melanoma: a model for direct IFN- anti-tumor cytotoxicity in vitro and in vivo

By Elaine G Rodrigues   Luiz R Travassos  

Cytokines, Cellular & Molecular Therapy, Vol. 7, Iss. 3, 2002-06 ,pp. : 107-116

Informa Healthcare

Access to resources Recommend Favorite

Inhibition of tumor growth and histopathological changes following treatment with a chemokine receptor CXCR4 antagonist in a prostate cancer xenograft model

By              

Oncology Letters, Vol. 6, Iss. 4, 2013-01 ,pp. : 933-938

Spandidos Publications

Access to resources Recommend Favorite

A comment on ''Scandinavian Sarcoma Group Osteosarcoma Study SSG VIII: prognostic factors for outcome and the role of replacement salvage chemotherapy for poor histological responders''

By Bacci G.   Longhi A.   Forni C.   Setola E.   Ferrari E.S.  

European Journal of Cancer, Vol. 39, Iss. 17, 2003-11 ,pp. : 2566-2566

Elsevier

Access to resources Recommend Favorite

Reply to comment on ''Scandinavian Sarcoma Group Osteosarcoma Study SSG VIII: prognostic factors for outcome and the role of replacement salvage chemotherapy for poor histological responders''

By Smeland S.   Muller C.   Saeter G.  

European Journal of Cancer, Vol. 39, Iss. 17, 2003-11 ,pp. : 2567-2568

Elsevier

Access to resources Recommend Favorite